Literature DB >> 2583561

Patterns of colonisation of Campylobacter pylori in the oesophagus, stomach and duodenum.

S J Walker1, P J Birch, M Stewart, C J Stoddard, C A Hart, D W Day.   

Abstract

Thirty five subjects underwent upper gastrointestinal endoscopy and multiple biopsy (30 patients, five normal subjects). A total of 11 biopsies per subject from four sites (oesophagus (three), gastric body (two), antrum (three), duodenum (three] were examined for inflammation and the presence of Campylobacter pylori and using standard methods of culture and by light (LM) and electron microscopy (EM). The organism was cultured from oesophageal biopsies in eight of 30 (27%) patients but could not be identified at this site by LM or EM. There was evidence of oesophageal inflammation in 20 patients which was associated with the local finding of C pylori in five (25%) including two of seven (29%) with Barrett's mucosa. Antral C pylori was present in 22 of 23 (96%) patients with chronic active gastritis. The organism was found in the antrum and oesophagus in four of 22 patients (18%), in the antrum and duodenum in four of 22 patients (18%) and in all three sites in a further two of 22 patients (9%). Antral C pylori was found in five of six patients with peptic ulceration. C pylori was cultured from the duodenum in six patients with confirmation by LN and EM in three, but only on areas of gastric metaplasia. The organism was not found in the normal group. This study indicates that C pylori may be irregularly isolated from the oesophagus and duodenum in patients with antral C pylori and chronic active gastritis. The role of C pylori in the oesophagus is most likely that of a commensal or contaminant.

Entities:  

Mesh:

Year:  1989        PMID: 2583561      PMCID: PMC1434412          DOI: 10.1136/gut.30.10.1334

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  The histologic spectrum of Barrett's esophagus.

Authors:  A Paull; J S Trier; M D Dalton; R C Camp; P Loeb; R K Goyal
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

2.  Campylobacter pyloridis--a new factor in peptic ulcer disease?

Authors:  B J Rathbone; J I Wyatt; R V Heatley
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

3.  Campylobacter-like organisms in the stomach of patients and healthy individuals.

Authors: 
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  Gastric spiral bacteria.

Authors: 
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

5.  Surface morphology of the gastroduodenal mucosa in duodenal ulceration.

Authors:  H W Steer
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

6.  Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies.

Authors:  D M Jones; A M Lessells; J Eldridge
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

7.  Gastro-oesophageal reflux and oesophagitis before and after vagotomy for duodenal ulcer.

Authors:  D Flook; C J Stoddard
Journal:  Br J Surg       Date:  1985-10       Impact factor: 6.939

8.  Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy.

Authors:  A B Price; J Levi; J M Dolby; P L Dunscombe; A Smith; J Clark; M L Stephenson
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

9.  Pyloric Campylobacter infection and gastroduodenal disease.

Authors:  B J Marshall; D B McGechie; P A Rogers; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

10.  Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium.

Authors:  S L Hazell; A Lee; L Brady; W Hennessy
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

View more
  9 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Campylobacter-like organisms in heterotopic gastric mucosa of the upper oesophagus.

Authors:  J F Flejou; F Potet; G Molas; W V Bogomoletz; S Nasca; C Rigaud; P Feydy; N Ectors; K Geboes
Journal:  J Clin Pathol       Date:  1990-11       Impact factor: 3.411

3.  Helicobacter pylori infection in patients with Barrett's oesophagus: a prospective immunohistochemical study.

Authors:  O Ricaurte; J F Fléjou; C Vissuzaine; D Goldfain; A Rotenberg; G Cadiot; F Potet
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

4.  Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus.

Authors:  V K Sharma; S E Demian; D Taillon; R Vasudeva; C W Howden
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

5.  Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus.

Authors:  M Newton; R Bryan; W R Burnham; M A Kamm
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

6.  H. pylori infection and reflux oesophagitis: a case-control study.

Authors:  Rahim Masjedizadeh; Eskandar Hajiani; Koorosh Moezardalan; Saeed Samie; Mohammad-Javad Ehsani-Ardakani; Ali Daneshmand; Mohammad-Reza Zali
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

7.  No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea.

Authors:  N Kim; S H Lim; K H Lee
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

8.  Relationship of gastric Helicobacter pylori infection to Barrett's esophagus and gastro-esophageal reflux disease in Chinese.

Authors:  Jun Zhang; Xiao-Li Chen; Kang-Min Wang; Xiao-Dan Guo; Ai-Li Zuo; Jun Gong
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

Review 9.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.